Scott Armstrong is president and chief executive officer (CEO) of Group Health Cooperative, one of the nation’s largest consumer-governed health care systems. He has been with Group Health since 1986 in positions ranging from assistant hospital administrator to chief operating officer. He became president and CEO in January 2005. He joined Group Health from Miami Valley Hospital in Dayton, Ohio, where he was the assistant vice president for hospital operations. He received a bachelor’s degree from Hamilton College in New York and a master’s degree in business with a concentration in hospital administration from the University of Wisconsin–Madison. Mr. Armstrong is a commissioner of the Medicare Payment Advisory Commission, a board member of the Alliance of Community Health Plans, and a board member of America’s Health Insurance Plans. He is also a fellow of the American College of Healthcare Executives.
Raymond J. Baxter, Ph.D., is Kaiser Permanente’s senior vice president for community benefit, research and health policy. As a member of Kaiser’s national executive team, Dr. Baxter leads the organization’s activities to fulfil its social mission, including care and coverage for low-income people, community health initiatives, health equity, environmental stewardship, and support for community-based organizations. He also leads Kaiser Permanente’s (KP’s) work in research, health policy, and diversity and serves as president of KP International. Dr. Baxter has more than 35 years of experience managing public health, hospital, long-term care, and mental health programs, including heading the San Francisco Department of Public Health and the New York City Health and Hospitals Corporation.
Dr. Baxter also led The Lewin Group, a noted health policy firm. Dr. Baxter holds a doctorate from the Woodrow Wilson School of Public and International Affairs at Princeton University. He serves on the advisory boards of the University of California (UC), Berkeley, School of Public Health and the Duke University Institute for Health Innovation, the board of the CDC (Centers for Disease Control and Prevention) Foundation, the Global Agenda Council on Health of the World Economic Forum, and the board of Archimedes, Inc., and he is a member of the Institute of Medicine’s (IOM’s) Roundtable on Population Health Improvement. In 2001 UC Berkeley School of Public Health honored him as a Public Health Hero for his service in the AIDS epidemic in San Francisco. In September 2006 he received the CDC Foundation Hero Award for addressing the health consequences of Hurricane Katrina in the Gulf Coast and for his longstanding commitment to improving the health of communities.
Barbara E. Bierer, M.D., is senior vice president for research at the Brigham and Women’s Hospital and professor of medicine at Harvard Medical School. Dr. Bierer, a graduate of Harvard Medical School, completed her internal medicine residency at the Massachusetts General Hospital and her hematology and medical oncology training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. Dr. Bierer maintained a research laboratory in the Department of Pediatric Oncology at Dana-Farber Cancer Institute and was appointed director of pediatric stem cell transplantation at Dana-Farber Cancer Institute and Children’s Hospital in 1993. In 1997 she was named chief of the Laboratory of Lymphocyte Biology at the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) in Bethesda, Maryland, where she received the Director’s Award in 1999. She returned to the Dana-Farber Cancer Institute in July 2002 as vice president of patient safety and director of the Center for Patient Safety. In 2003 Dr. Bierer moved to the Brigham and Women’s Hospital to assume her current position. In 2006 Dr. Bierer established the Center for Faculty Development and Diversity at the Brigham and Women’s Hospital and now serves as its first director. For these efforts she was the first recipient of the HMS Harold Amos Faculty Diversity Award in 2008. In addition, Dr. Bierer is the co-chair of the Partners Healthcare Committee on Conflict of Interest and the program director of the regulatory domain of the Harvard Catalyst, the Harvard Clinical and Translational Science Award. Dr. Bierer maintained until recently a research laboratory focusing on the biochemistry of T cell activation and immunosuppression. She has authored or co-authored over 150 publications and is on the editorial boards of a number of journals, including Current Protocols of Immunology. In addition to her academic responsibilities, Dr. Bierer was elected to the board of directors of the Association for Accreditation of Human Re-
search Protection Programs, serving as its president from 2003 to 2007, and was on the board of directors of the Federation of American Societies for Experimental Biology. She was a member of the medical and scientific advisory board and, later, the board of directors of ViaCell, Inc. She is currently a member of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Clinical Research, on the National Academy of Sciences (NAS) Committee on Science, Technology, and the Law, and on the Secretary’s Advisory Committee for Human Research Protections, U.S. Department of Health and Human Services (HHS), for which she serves as chair.
Mary Brainerd, M.B.A., has been a leader in health care since 1984. Prior to joining HealthPartners in 1992, Ms. Brainerd held senior level positions with Blue Cross and Blue Shield of Minnesota, including senior vice president and chief marketing officer. She was also senior vice president and CEO of Blue Plus. Before that, she was a marketing instructor in the graduate program at Metropolitan State University. Ms. Brainerd is one of the founding CEOs of the Itasca Project, a group of 40 government, civic, and business leaders addressing the issues that affect long-term economic growth, including jobs, education, transportation, and economic disparities. She also serves on the boards of Minnesota Life/Securian, the Minnesota Council of Health Plans, The St. Paul Foundation, the Minneapolis Federal Reserve, and SurModics.
Patrick Conway, M.D., M.Sc., is the deputy administrator for innovation and quality and chief medical officer at the Centers for Medicare & Medicaid Services (CMS). He leads the Center for Clinical Standards and Quality (CCSQ) and the Center for Medicare & Medicaid Innovation (CMMI) at CMS. CCSQ is responsible for all quality measures for CMS, value-based purchasing programs, quality improvement programs in all 50 states, clinical standards and survey and certification of Medicare and Medicaid health care providers across the nation, and all Medicare coverage decisions for treatments and services. The center, whose annual budget exceeds $2 billion, is a major force for quality and transformation across Medicare, Medicaid, the Children’s Health Insurance Program, and the U.S. health care system. The CMS Innovation Center is responsible for testing numerous new payment and service delivery models across the nation. Models include accountable care organizations, bundled payments, primary care medical homes, state innovation models, and many more. Successful models can be scaled nationally. The CMS Innovation Center budget is $10 billion over 10 years. Previously, Dr. Conway was director of hospital medicine and an associate professor at Cincinnati Children’s Hospital. He was also assistant vice president of outcomes performance, responsible for leading measurement, including the electronic health record
(EHR) measures, and facilitating improvement of health outcomes across the health care system. Other relevant experience includes previous work as the chief medical officer at HHS in the Office of the Assistant Secretary for Planning and Evaluation. In 2007–2008, he was a White House Fellow assigned to the Office of Secretary in HHS and the Director of the Agency for Healthcare Research and Quality (ARHQ). He also served as executive director of the Federal Coordinating Council on Comparative Effectiveness Research (CER), coordinating the investment of the $1.1 billion for CER in the Recovery Act. He was a Robert Wood Johnson Foundation (RWJF) Clinical Scholar and completed a master’s of science focused on health services research and clinical epidemiology at the University of Pennsylvania and Children’s Hospital of Philadelphia. Previously, he was a management consultant at McKinsey & Company, serving senior management of mainly health care clients on strategy projects. He has published articles in journals such as JAMA, New England Journal of Medicine, Health Affairs, and Pediatrics and has given national presentations on topics including health care policy, quality of care, comparative effectiveness, hospitalist systems, and quality improvement. He is a practicing pediatric hospitalist and was selected as a Master of Hospital Medicine from the Society of Hospital Medicine. He completed a pediatrics residency at Harvard Medical School’s Children’s Hospital Boston, graduated with high honors from Baylor College of Medicine, and graduated summa cum laude from Texas A&M University.
Steven J. Corwin, M.D., was named CEO of New York-Presbyterian Hospital on September 6, 2011. In this role he is responsible for developing and implementing the hospital’s next capital and fundraising plan; advocating for academic medicine under health care reform; further integrating electronic information systems across the care continuum; collaborating with the hospital’s medical school partners and health care system to support patient care, education, and research; and continuing to improve community health status. Previously, Dr. Corwin served as executive vice president and chief operating officer for New York-Presbyterian Hospital, a position he held beginning in 2005. In addition to overseeing the day-to-day operations across all five campuses of the hospital, Dr. Corwin was responsible for advancing the institution’s strategic initiatives to fulfill its commitment to We Put Patients First, at the core of its mission. This included an intense focus on quality and patient safety, cultivating the organization’s people and talent, advancing clinical and technological innovation, building physician and institutional partnerships across the New York-Presbyterian enterprise, ensuring service to the hospital’s underserved communities, and maintaining the hospital’s financial and operational strength. Key accomplishments under Dr. Corwin’s leadership include marked improvements in quality and
safety across the institution, improved patient and employee satisfaction, significant program growth and ranking among the top six hospitals in the nation, advancement of major construction projects, joint information systems planning with the hospital’s partner medical schools, and robust financial and operating results. Dr. Corwin has been at the hospital since 1979. He joined the former Columbia-Presbyterian Medical Center’s management team in 1991 and served in various management capacities. From 1998 to 2005 Dr. Corwin served as senior vice president and chief medical officer for New York-Presbyterian, leading the development and implementation of 13 clinical service lines, an initiative that was critical to the success of the newly merged hospital. In this role, he forged strong clinical collaborations across the institution to foster a solid partnership among physicians and hospital management. A cardiologist and internist, Dr. Corwin obtained his undergraduate and medical degrees from Northwestern University, graduating summa cum laude and as a member of the Alpha Omega Alpha honors society. He completed both his internal medicine residency and cardiology training at Columbia-Presbyterian Medical Center. Dr. Corwin is a member of the board of directors of the Greater New York Hospital Association Foundation and serves as assistant treasurer. He is a fellow of the New York Academy of Medicine, a member of the Association of American Medical Colleges Council of Teaching Hospitals administrative board, a member of the Health Management Academy, and a member of the advisory board for the Morgan Stanley Institute for Sustainable Investing. Dr. Corwin has received numerous awards. He was a 2013 recipient of the Our Town Thanks You Award for his efforts in improving Manhattan’s Upper East Side community. He was also a 2013 recipient of the Northwestern Alumni Award. His other previous awards include the Hope and Heroes Award, the Veterans Health Administration (VHA) Award for Clinical Quality, the Health Care Industry Good Scout Award, and an Honorary Physician-of-the-Year Award presented to him by the New York-Presbyterian/Columbia Division of Nursing.
Ronald A. DePinho, M.D., is president of the University of Texas MD Anderson Cancer Center in Houston. His research program has focused on the molecular underpinnings of cancer, aging and degenerative disorders, and the translation of such knowledge into clinical advances. Dr. DePinho’s independent scientific career began at the Albert Einstein College of Medicine, where he was the Feinberg Senior Faculty Scholar in Cancer Research. He then joined the Department of Medical Oncology at the Dana-Farber Cancer Institute and the Department of Medicine and Genetics at the Harvard Medical School. He was the founding director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute and a professor of medicine and genetics at Harvard Medical School. Dr. DePinho
is a former member of the board of directors of the American Association for Cancer Research, and he has served on numerous advisory boards in the public and private sectors, including being co-chair of advisory boards for the National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium and for the Cancer Genome Atlas Project. Dr. DePinho studied biology at Fordham University, where he graduated class salutatorian, and received his M.D. degree with distinction in microbiology and immunology from the Albert Einstein College of Medicine. For his fundamental contributions to cancer and aging, he has received numerous honors and awards including the March of Dimes Basil O’Connor Scholar Award, the James S. McDonnell Foundation Scholar Award, the Cancer Research Institute Investigator Award, the Melini Award for Biomedical Excellence, the Irma T. Hirschl Career Scientist Award, the Kirsch Foundation Investigator Award, and the Richard P. and Claire W. Morse Scientific Award. He is the recipient of the 2002 American Society for Clinical Investigation Award, the 2003 AACR G.H.A. Clowes Memorial Award, the 2007 Biomedicum Helsinki Medal, and the 2009 Albert Szent-Györgyi Prize. He is a member of the IOM of the NAS. In 2010 Dr. DePinho was elected to membership in the American Academy of Arts and Sciences. In 2012 he was elected as a member of the NAS. He is a founder of a number of biopharmaceutical companies focused on cancer therapies and diagnostics.
Karen DeSalvo, M.D., M.P.H., M.Sc., is a physician who has focused her 20-year career on improving access to affordable, high-quality care for all people, with a focus on vulnerable populations and improving overall health. She has done this through direct patient care, medical education, and policy and administrative roles and as a researcher. As the National Coordinator for Health Information Technology, she is leading the nation’s charge to promote, adopt, and meaningfully use health information technology in order to achieve better care and lower costs in health care and improve the overall health of everyone in America. Before joining HHS, she was health commissioner for the City of New Orleans and New Orleans Mayor Mitchell Landrieu’s senior health policy advisor. While there, she transformed the outmoded health department into a modern and effective one and restored health care to devastated areas of the city, including leading the establishment of a public hospital. Prior to joining the mayor’s administration, Dr. DeSalvo was a professor of medicine and vice dean for community affairs and health policy at the Tulane University School of Medicine. A physician with training and experience in internal medicine and public health, following Hurricane Katrina she was a leader in building an innovative and award-winning model of neighborhood-based primary care and mental health services, with a sophisticated health information technology infrastructure for low-income, uninsured, and other types of
vulnerable individuals. Dr. DeSalvo served as president of the Louisiana Health Care Quality Forum, the state’s lead for the health information exchange, and as president of the National Association of Chiefs of General Internal Medicine. She has served on the boards of the National Association of County and City Health Officials and the Society of General Internal Medicine. Dr. DeSalvo was recognized as a “Woman of Excellence in Health Care” by the Louisiana Legislative Women’s Caucus. In 2013 Governing Magazine named Dr. DeSalvo one of nine public officials of the year. The American Medical Student Association recognized her with a Women’s Leader Award in 2014. She earned her medical doctorate and master’s degree in public health from Tulane University and a master’s in clinical epidemiology from the Harvard School of Public Health. She has an honorary doctorate from her undergraduate institution, Suffolk University.
Victor J. Dzau, M.D., became the eighth president of the IOM on July 1, 2014. Before that he was chancellor for health affairs and the James B. Duke Professor of Medicine at Duke University and the past president and CEO of Duke University Health System. Previously Dr. Dzau had been the Hersey Professor of Theory and Practice of Medicine and the chairman of medicine at Harvard Medical School’s Brigham and Women’s Hospital and, before that, the chairman of Department of Medicine at Stanford University. Dr. Dzau has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics, his pioneering work in the discipline of vascular medicine, and, recently, his leadership in health care innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as therapeutics. Dr. Dzau also pioneered gene therapy for vascular disease, and his recent work on stem cell “paracrine mechanism” and the use of microRNA in direct reprogramming provide novel insight into stem cell biology and regenerative medicine. In his role as a leader in health care, Dr. Dzau has led efforts in health care innovation. His vision is for academic health sciences centers to lead the transformation of medicine through innovation, translation, and globalization. Leading this vision at Duke, he and colleagues developed the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke–National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation. These initiatives create a seamless continuum from discovery and translational sciences to clinical care and promote transformative innovation in health. As one of the world’s preeminent academic health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has served as a member of the council of the IOM and of the Advisory Committee to the Director of the NIH and as the chair of the NIH Cardiovascular Disease
Advisory Committee and of the Association of Academic Health Centers. Currently he is a member of the board of directors of the Singapore Health System, the governing board of Duke–National University Singapore Medical School, and a senior health policy advisor to Her Highness Sheikha Moza (the chair of Qatar Foundation). He is also on the board of health governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine. In 2011 he led a partnership among Duke University, the World Economic Forum, and McKinsey. He founded the nonprofit organization International Partnership for Innovative Healthcare Delivery and chairs its board of directors. Among his honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine; the Max Delbruck Medal from Humboldt University, Charite and the Max Planck Institute; the Commemorative Gold Medal from Ludwig Maximillian University of Munich; the Inaugural Hatter Award from the Medical Research Council of South Africa; the Polzer Prize from the European Academy of Sciences and Arts; the Novartis Award for Hypertension Research; the Distinguished Scientist Award from the American Heart Association (AHA); and the 2010 AHA Research Achievement Award for his contributions to cardiovascular biology and medicine. He has received six honorary doctorates.
Thomas L. Garthwaite, M.D., is the chief operating officer and vice president of the HCA Clinical Services Group. Before joining HCA, Dr. Garthwaite served as the executive vice president and chief medical officer for Catholic Health East, the director and chief medical officer of the Los Angeles County Department of Health Services, and under secretary for health at the Veterans Health Administration (VHA) in Washington, DC. At the U.S. Department of Veterans Affairs (VA) he helped lead the transformation of the system to achieve excellence in care quality and implement its use of computerized health records.
Thomas Graf, M.D., is the chief medical officer for population health and longitudinal care service lines for Geisinger Health System. Dr. Graf is responsible for the Value Re-Engineering of the Care Continuum and other population health initiatives for Geisinger including the accountable care organization portfolio and, with CMS, the Physician Group Practice Transitions Demonstration and Bundled Payments for Care Improvement. He leads the community practice, internal medicine, pediatrics, psychiatry, and care continuum service lines in coordinating and accelerating population-health-related activities across 22 counties in central and northeast Pennsylvania. He is recognized nationally as a leader in medical home and post-acute care redesign.
Sarah Greene, M.P.H., is a senior program officer with the Methods and Infrastructure Program at the Patient-Centered Outcomes Research Institute (PCORI). She is responsible for providing intellectual and organizational leadership for the program, primarily working with awardees on PCORI’s National Patient-Centered Clinical Research Network, PCORnet. Ms. Greene’s research has included patient-centered communication, health literacy, quality of cancer care, improving the human subjects research process, and optimization of multisite collaboration. At the Group Health Research Institute, she served leadership roles on federally funded consortium projects, including the Cancer Research Network, Cancer Communication Research Center, and the HMO Research Network. As a member of the Clinical & Translational Science Awards consortium, Greene chaired the national community partners integration work group. Most recently, as a health care strategy consultant for Group Health Cooperative, she led initiatives on improving patient service, cancer outcomes measurement, and branding. Greene has authored numerous manuscripts focused on development and implementation of multicenter research, and she created ResearchToolkit.org, which aggregates publicly available resources related to conduct of health research studies. She received both an M.P.H., with an emphasis in epidemiology, and a B.A. in psychology and Italian from Indiana University.
David Grossman, M.D., M.P.H., is currently the medical director for population and purchaser strategy at Group Health Cooperative and also a senior investigator at the Group Health Research Institute. As a senior medical enterprise medical director, he serves as the medical director assisting with population strategy for some of Group Health’s largest purchasers, including the Federal Employee Health Benefit Program and Washington Public Employees Benefit Board. He also leads the new enterprise strategy on population health management and has overseen the development of clinical guidelines for preventive and care management interventions and policy. In addition to his roles with the Health Plan Division, Dr. Grossman also is a senior research investigator for the Group Health Research Institute, where he has led many highly applied research and evaluation projects in his career. Dr. Grossman currently leads the Institute’s participation in both the Kaiser Permanente Research Affiliates evidence-based practice center and federally funded research studies, including a study for value-based insurance design. He has more than 120 publications encompassing many aspects of injury control, Native American health, health services research, and evidenced-based medicine and has been recognized by CDC as one of the most influential injury and violence prevention professionals over the past 20 years. He is also a professor of health services and an adjunct professor of pediatrics at the University of Washington. He
works as a part-time board-certified pediatrician at Group Health’s Factoria Medical Center. Dr. Grossman has served on a number of key regional and national advisory boards, including the Task Force for Community Preventive Services, CDC (Community Guide, current); Washington Health Alliance, member of board and treasurer (current); U.S. Preventive Services Task Force (USPSTF) (2008–2013); board of scientific counselors, CDC (2004–2013).
Ed Havranek, M.D., directs the Center for Health Systems Research at Denver’s safety net health care system, Denver Health (DH). The center is engaged in a broad range of activities, including leading DH’s engagement in the High Value Healthcare Collaborative and developing patient-centered outcomes research infrastructure at DH under a grant from the Agency for Healthcare Research and Quality. He is also a professor of medicine at the University of Colorado School of Medicine. He graduated from the University of Vermont College of Medicine and trained in internal medicine at the University of Colorado Health Sciences Center and in cardiology at the University of Wisconsin Hospital. He has been on the faculty in Colorado since 1991. From 1999 to 2005 he was also a clinical coordinator for the National Heart Care project, a nationwide quality-improvement effort in heart failure and acute myocardial infarction sponsored by CMS. His personal research interests are currently focused on the effects of racial and ethnic bias on health care.
Trent Haywood, M.D., J.D., is chief medical officer for the Blue Cross Blue Shield Association (BCBSA), a national federation of 37 independent, community-based, and locally operated Blue Cross and Blue Shield companies. The Blue System is the nation’s largest health insurer, covering more than 100 million people, or approximately one in three Americans. As the association’s chief medical officer, Dr. Haywood is responsible for the Office of Clinical Affairs, which includes the Center for Clinical Effectiveness, the Center for Clinical Practices, and the Center for Clinical Value. Dr. Haywood leads the National Council of Physician Executives, which consists of chief medical officers and chief pharmacy executives who guide the clinical direction across BCBS companies. Dr. Haywood provides clinical leadership for the 5.3-million-member Federal Employee Program. In addition, Dr. Haywood provides clinical guidance to Blue Health Intelligence, an independent licensee of the BCBSA.
Rodney F. Hochman, M.D., serves as president and CEO of Providence Health & Services, leading the five-state health system. Before serving as group president and now president and CEO of Providence, Dr. Hochman was president and CEO of Swedish Health Services. He and his team
helped transform Swedish and positioned the organization for a strong, stable future. In his 5 years at Swedish he strengthened the community safety net, created a strong culture of safety, and reinvented their business model from a downtown hospital focus to a regional system of care. Knowing that greater collaboration among providers was the future of health care, Dr. Hochman and the Swedish board conducted an exhaustive search over the course of his tenure and aligned Swedish with the right partner—Providence. Prior to joining Swedish, Dr. Hochman had been executive vice president since 2004 of Sentara Healthcare, a major medical system based in Norfolk, Virginia. In that role he was responsible for the operation of five hospitals as well as the organization’s medical group and legal and corporate compliance divisions. Prior to that position, he had served as Sentara’s chief medical officer and senior vice president beginning in 1998. Before joining Sentara, Dr. Hochman held numerous executive-level positions during 5 years with the Health Alliance of Greater Cincinnati, and he spent nearly 10 years with Guthrie Healthcare System in Sayre, Pennsylvania. His medical background is in rheumatology and internal medicine, and he has served as a clinical fellow in internal medicine at Harvard Medical School and Dartmouth Medical School. In addition, Dr. Hochman is a fellow of the American College of Physicians, a fellow of the American College of Rheumatology, and a member of the American College of Healthcare Executives. He is the recipient of the 2001 Physician Executive Award of Excellence, sponsored by Modern Physician magazine, and under his leadership, 569-bed Sentara Norfolk General Hospital won the American Hospital Association’s (AHA’s) prestigious Quest for Quality national award in 2002. In May 2009 Dr. Hochman was honored for the second time by Modern Physician magazine as number 11 of the 50 Most Powerful Physician Executives in Healthcare. He earned his medical degree from Boston University School of Medicine and his bachelor’s degree from Boston University.
Susan Huang, M.D., M.P.H., is an associate professor in the Division of Infectious Diseases and the Health Policy Research Institute at the University of California (UC), Irvine, School of Medicine and is the medical director of epidemiology and infection prevention at UC Irvine Health. She received her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Harvard School of Public Health in quantitative methods. Her clinical epidemiologic research has focused on health care–associated infections—identifying the population burden, risk factors for acquisition and disease sequelae, and preventive strategies for containment. Dr. Huang is currently the lead investigator of three randomized clinical trials on preventing methicillin-resistant Staphylococcus aureus disease and other health care–associated infections. She serves as a member of the Healthcare Infec-
tion Control Practices Advisory Committee, a 14-member federal advisory committee that develops guidelines on infection control and prevention in health care settings. She is also a member of the board of scientific counselors for the Antibiotic Resistance Working Group for CDC, the Antibiotic Resistance Committee for the Infectious Diseases Society of America, and the Clinical Effectiveness Research Innovation Collaborative at the IOM.
Brent C. James, M.D., M.Stat., is the executive director of the Institute for Health Care Delivery Research and vice president of medical research and continuing medical education at Intermountain Healthcare. He has championed the standardization of clinical care through data collection and analysis on a wide variety of treatment protocols and complex care processes. He has devoted himself to using quality-improvement tools to better understand the cause-and-effect relationship between various practice and environmental factors. Today, nearly 100 years after his mentors’ groundbreaking discoveries, Dr. James firmly believes that the practice of medicine and the delivery of health care stand at another critical crossroads. If the health care field is to successfully bridge the quality chasm defined by the IOM, a new and innovative approach to the practice of health care is mandatory. Dr. James feels strongly that the time has come to shift from “craft-based” practice to evidence-directed teams focused on patient care. In addition to his duties at Intermountain Healthcare, Dr. James is an adjunct professor at the University of Utah School of Medicine in the Department of Family and Preventive Medicine. He also holds a visiting lectureship in the Department of Health Policy and Management at the Harvard School of Public Health. He is a member of a number of national task forces and committees that examine health care quality and cost control, including AHRQ, and his most recent appointment is by the federal comptroller to an advisory group on making American health care more accessible and affordable. In 2005 Dr. James also received an award from the National Committee for Quality Assurance recognizing his vision and energy in making the U.S. health care system better.
Nancy Kass, Sc.D., is the Phoebe R. Berman Professor of Bioethics and Public Health in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health and is deputy director for public health in the Berman Institute of Bioethics. In 2009–2010 Dr. Kass was based in Geneva, Switzerland, where she was working with the World Health Organization Ethics Review Committee Secretariat. Dr. Kass received her B.A. from Stanford University, completed doctoral training in health policy from the Johns Hopkins School of Public Health, and was awarded a National Research Service Award to complete a postdoctoral fellowship in bioethics at the Kennedy Institute of Ethics at Georgetown
University. Dr. Kass conducts empirical work in bioethics and health policy. Her publications are primarily in the field of U.S. and international research ethics, HIV/AIDS ethics policy, public health ethics, and ethics of public health preparedness. She is co-editor of HIV, AIDS and Childbearing: Public Policy, Private Lives (Oxford University Press, 1996). Dr. Kass co-chaired the NCI Committee to Develop Recommendations for Informed Consent Documents for Cancer Clinical Trials, and she served on the NCI’s central institutional review board. She has served as consultant to the President’s Advisory Committee on Human Radiation Experiments, to the National Bioethics Advisory Commission, and to the NAS. Current research projects examine ethics for a learning health care system, including quality improvement and comparative effectiveness, informed consent in randomized trials, ethics issues that arise in international health research, and ethics and public health preparedness. Dr. Kass teaches the Bloomberg School of Public Health’s course on U.S. and International Research Ethics and Integrity, is the director of the school’s Ph.D. program in bioethics and health policy, and is the director of the Johns Hopkins Fogarty African Bioethics Training Program. Dr. Kass is an elected member of the IOM and a fellow of the Hastings Center.
Rainu Kaushal, M.D., M.P.H., chairman of the Department of Healthcare Policy and Research at Weill Cornell Medical College, is an international expert and leader in the clinical effectiveness, cost effectiveness, and comparative effectiveness of health care delivery interventions and models. Dr. Kaushal is also executive director of the Center for Healthcare Informatics and Policy, the Frances and John L. Loeb Professor of Medical Informatics at Weill Cornell Medical College, and chief of health care policy and research at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Kaushal’s extensive research portfolio covers topics central to health care delivery and reform, including health information technology, health information exchange, and novel models of health care delivery and provider payment. She studies the effects of these health care interventions on outcomes related to health care quality, safety, costs, value, provider adoption, provider usage, and patient satisfaction. These studies include those conducted by the Health Information Technology Evaluation Collaborative, which she leads and which has played an instrumental role in New York State’s health reform program. Dr. Kaushal also currently leads a $7 million grant from PCORI to establish a clinical data research network involving 22 New York City organizations. The consortium will develop a data infrastructure to support a wide variety of research studies and the recruitment of patients into clinical trials. Dr. Kaushal was recently selected as a fellow in the 2014–2015 class of the prestigious Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women at Drexel Univer-
sity College of Medicine. She has more than 125 scholarly publications, has served on numerous national and international advisory committees, has formally consulted with other researchers as well as with policy makers, and has served on editorial boards for health care journals as well as on several study sections for AHRQ. Dr. Kaushal is a frequent invited national and international speaker.
Pete Knox, M.S., executive vice president and chief learning and innovation officer of Bellin Health System, has been associated with Bellin Health in Green Bay, Wisconsin, in a variety of leadership roles for the past 34 years. Mr. Bellin has been on the leading edge of quality for many years and is recognized nationally for superior results. In his current role he is responsible for population health strategies, physician networks, employer strategies, learning and innovation, and execution of strategy. In addition, he is a consultant for health care and other organizations and is a senior fellow at the Institute for Healthcare Improvement. His book titled The Business of Health Care is being used by a number of universities and organizations across the country and he is currently working on a second book, The Strategy Execution Playbook.
Uma R. Kotagal, M.B.B.S., M.Sc., is senior vice president for quality, safety, and transformation and executive director of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital Medical Center. As director of the Anderson Center, Dr. Kotagal oversees the development of disease management teams and development and institution of evidence-based clinical practice guidelines. Dr. Kotagal was director of the neonatal intensive care units at the University Hospital and at Cincinnati Children’s. She received her master of science in clinical epidemiology and clinical effectiveness from the Harvard School of Public Health, and she refocused her clinical efforts on quality transformation at a systems level. She served as a visiting scholar at the Center for Risk Analysis at the Harvard School of Public Health and as a visiting professor at the Tufts New England Medical Center in the Division of Clinical Decision Making, completing further training in the field of decision and cost-effectiveness analyses. Dr. Kotagal was born in Bombay, India, where she received her undergraduate and her M.B.B.S. from the University of Bombay. She completed rotating internships at the University of Bombay and at Detroit General Hospital. At Children’s Hospital of Michigan, Dr. Kotagal completed her pediatric residency, and she went on to do a fellowship in neonatology. She completed a fellowship in neonatal physiology at the University of Cincinnati. Dr. Kotagal is president of the Academy of Healthcare Improvement and a faculty member of the Institute for Healthcare Improvement. She also serves on the board of directors and as chair
of the quality steering team of the Ohio Children’s Hospital Association, as a member of the advisory committee of the Toronto Patient Safety Center, as an associate editor of BMJ Quality and Safety, and as a member of the IOM.
David Labby, M.D., Ph.D., is chief medical officer of Health Share of Oregon, a coordinated care organization with more than 160,000 enrollees in the tricounty area (Multnomah, Clackamas, and Washington), encompassing Portland and including all major hospital and health systems along with providers, including those in safety net practices. Previously he served as medical director for CareOregon, the state’s largest Medicaid managed-care plan. During his career, Dr. Labby has practiced in primary care and was medical director of both primary care and multi-specialty settings before coming to CareOregon in 2000. He received his Ph.D. in cultural anthropology.
Eric B. Larson, M.D., M.P.H., MACP, is the vice president for research of Group Health and the executive director of the Group Health Research Institute. A graduate of Harvard Medical School, he trained in internal medicine at Beth Israel Hospital in Boston, completed an RWJF Clinical Scholars and an M.P.H. program at the University of Washington (UW), and then served as chief resident of University Hospital in Seattle. He served as medical director of University of Washington Medical Center and as associate dean for clinical affairs from l989 to 2002. His research spans a range of general medicine topics and has focused on aging and dementia, including a long-running study of aging and cognitive change set in the Group Health Cooperative—The UW/Group Health Alzheimer’s Disease Patient Registry/Adult Changes in Thought Study. He has served as president of the Society of General Internal Medicine, chair of the OTA/DHHS Advisory Panel on Alzheimer’s Disease and Related Disorders, and chair of the board of regents of the American College of Physicians from 2004 to 2005. He is an elected member of the IOM.
Harold S. Luft, Ph.D., is director of the Palo Alto Medical Foundation Research Institute and professor emeritus in the Philip R. Lee Institute for Health Policy Studies at UC San Francisco, where he was director from 1993 through 2007. Dr. Luft received degrees in economics from Harvard University and was a postdoctoral fellow there. He is an elected member of the IOM. He served 6 years on the IOM Council, chaired the national advisory council of the predecessor to ARHQ, and served 10 years on the board of AcademyHealth. From 1997 to 2006 he was senior associate editor and then co-editor of Health Services Research. His research has covered a wide range of topics, including health maintenance organizations,
hospital competition, volume, quality and outcomes of hospital care, risk assessment and risk adjustment, health care reform, and the use of information and incentives to increase value. He has authored or co-authored more than 200 articles in scientific journals and 5 books, including Total Cure: The Antidote to the Health Care Crisis (Harvard University Press, 2010).
Peter Margolis, M.D., Ph.D., is a professor of pediatrics and the director of research at the James M. Anderson Center for Health System Excellence at Cincinnati Children’s Hospital Medical Center. His work encompasses the application and study of quality-improvement methods in a broad range of areas, including primary and sub-specialty care, communities, and public health settings, to improve the health outcomes of children, families, and communities. In 2006 Dr. Margolis’ joined Cincinnati Children’s Hospital Medical Center to create a new center focused on health care quality. Dr. Margolis has worked extensively with the certifying boards and specialty societies to assist them in designing programs that will enable physicians to meet new maintenance of certification requirements focused on systems thinking and performance in practice. He is principle investigator of an National Institutes of Health Roadmap transformative research grant on redesigning systems for chronic illness care and several grants from ARHQ and PCORI aimed at developing learning health systems.
J. Michael McGinnis, M.D., M.A., M.P.P., is a physician, epidemiologist, and long-time contributor to national and international health programs and policy. An elected member of the IOM of the NAS, he has since 2005 also served as the senior scholar and executive director of the IOM Roundtable on Value & Science-Driven Health Care. He founded and stewards the IOM’s Learning Health System Initiative and, in prior posts, also served as founding leader for the RWJF’s Health Group, the World Bank/European Commission’s Task Force for Health Reconstruction in Bosnia, and, in the U.S. government, the Office of Research Integrity, the Nutrition Policy Board, and the Office of Disease Prevention and Health Promotion. In the latter post he held continuous policy responsibilities for prevention through four administrations (presidents Carter, Reagan, Bush, and Clinton), during which time he conceived and launched a number of initiatives of ongoing policy importance, including the Healthy People national goals and objectives, USPSTF, the Dietary Guidelines for Americans, and development of the Ten Essential Services of Public Health. At RWJF, he founded the Health & Society Scholars program, the Young Epidemiology Scholars program, and the Active Living family of programs. Early in his career he served in India as epidemiologist and state director for the World Health Organization’s Smallpox Eradication Program. Widely published, he has made foundational contributions to understanding the basic determinants of health
(e.g., “Actual Causes of Death,” JAMA 270:18  and “The Case for More Active Policy Attention to Health Promotion,” Health Affairs 21:2 ). National leadership awards include the Arthur Flemming Award, the Distinguished Service Award for public health leadership, the Health Leader of the Year Award, and the Public Health Hero Award. He has held visiting or adjunct professorships at George Washington, UC Los Angeles (UCLA), Princeton, and Duke universities. He is a graduate of UC Berkeley, the UCLA School of Medicine, and the John F. Kennedy School of Government at Harvard University and was the graduating commencement speaker at each.
Elizabeth A. McGlynn, Ph.D., is the director of Kaiser Permanente’s Center for Effectiveness and Safety Research (CESR). She is responsible for the strategic direction and scientific oversight of CESR, a virtual center designed to improve the health and well-being of Kaiser’s 9 million members and the public by conducting comparative effectiveness and safety research and implementing findings in policy and practice. She is the principal investigator for the Kaiser Permanente–led clinical data research network, PORTAL, an infrastructure development contract that is part of PCORnet, funded by PCORI. Dr. McGlynn is an internationally known expert on methods for evaluating the appropriateness, quality, and efficiency of health care delivery. She has conducted research in the United States and in other countries. Dr. McGlynn has also led major initiatives to evaluate health reform options under consideration at the federal and state levels. She received AcademyHealth’s Distinguished Investigator Award in 2012. Dr. McGlynn is a member of the IOM. She is vice-chair of the American Board of Internal Medicine Foundation board of trustees. She is on the board of AcademyHealth (former chair), the IOM Board of Health Care Services, and the Reagan–Udall Foundation for the Food and Drug Administration (FDA). She chairs the scientific advisory group for the Institute for Healthcare Improvement. She co-chairs the coordinating committee for the National Quality Forum’s Measures Application Partnership. She serves on the editorial boards for Health Services Research and The Milbank Quarterly and is a regular reviewer for many leading journals. Dr. McGlynn received her B.A. in international political economy from the Colorado College, her M.P.P. from the University of Michigan’s Gerald R. Ford School of Public Policy, and her Ph.D. in public policy analysis from the Pardee RAND Graduate School.
Janice Nevin, M.D., M.P.H., became Christiana Care Health System’s chief medical officer in 2011. As chief medical officer, Dr. Nevin is primarily responsible for advancing the mission of Christiana Care with regard to patient safety, clinical excellence, and patient satisfaction. She works closely with system leadership, clinical chairs, physicians, nursing leaders,
and others to ensure that patient-centered outcomes achieve system goals. She is also Christiana Care’s patient safety officer and provides oversight of Christiana Care’s medical education programs, including the Delaware Branch Campus of Jefferson Medical College and 280 residents and fellows. Dr. Nevin completed a program in executive education at Harvard Business School in 2010 and a fellowship in physician executive leadership at Health Management Academy in 2009. From 2008 until her appointment as chief medical officer, Dr. Nevin served as the senior vice president and executive director of Christiana Care Wilmington as well as the associate chief medical officer. In this role she was responsible for all clinical activity and operations at the Christiana Care Wilmington campus. In addition she provided leadership for the $210 million expansion project that began in 2009 at the Wilmington campus. Dr. Nevin worked with nursing leadership to develop a patient- and family-centered focus at Wilmington. The project led to the development of several new initiatives that emphasize patient- and family-centered care and resulted in significant improvements in preventing hospital-acquired infections, reductions in length of stay, increased patient satisfaction scores, and improvements in quality measures. From 2002 to 2008 Dr. Nevin was the chair of the Department of Family and Community Medicine at Christiana Care Health System. During this time she was also the medical director of the Christiana Care Visiting Nurse Association and clinical chair of Women First, the Community Center of Excellence in Women’s Health. Before joining Christiana Care Health System, Dr. Nevin was a faculty member and the residency program director in the Department of Family and Community Medicine at Jefferson Medical College. Dr. Nevin graduated from Harvard University in 1981 and received her doctorate in medicine with honors from Jefferson Medical College in 1987. She completed her family-medicine residency at Thomas Jefferson University Hospital in 1990 and received her master’s degree in public health in community health services from the University of Pittsburgh Graduate School of Public Health in 1992. She also finished a 2-year faculty-development fellowship in family medicine at St. Margaret Hospital in Pittsburgh.
Sally Okun, R.N., M.M.H.S., is the vice president for advocacy, policy, and patient safety at PatientsLikeMe in Cambridge, Massachusetts. She is responsible for patient voice and advocacy initiatives, participates in health policy discussions at the national and global level, and acts as the company’s liaison with government and regulatory agencies. She joined PatientsLikeMe in 2008 as the manager of health data integrity and patient safety, overseeing the site’s medical ontology, including the curation of patient-reported health data and patient folksonomy. In 2009 she developed the PatientsLikeMe Drug Safety and Pharmacovigilance Platform to meet adverse event report-
ing obligations of industry partners while collaborating in a social media environment. Ms. Okun participates on numerous collaboratives of the IOM’s Roundtable on Value & Science-Driven Health Care and the Committee on Core Metrics for Better Health at Lower Cost. Ms. Okun serves on the Advisory Panel on Patient Engagement for PCORI, the National Quality Forum’s Person-Centered Care and Outcomes Committee, the scientific advisory committee for the Reagan–Udall Foundation’s Innovation in Medical Evidence Development and Surveillance Program, and the program advisory board of the Schwartz Center for Compassionate Health Care. Ms. Okun is a frequent speaker at clinical, advocacy, and policy events, and in April 2013 she was the first nurse invited to give a TEDMED talk at Kennedy Center. Prior to joining PatientsLikeMe, Ms. Okun, a registered nurse, practiced as a community-based palliative and end-of-life care specialist and project consultant contributing to clinical, research, and educational projects with multiple collaborators, including Brown University, Harvard Medical School, the Massachusetts Department of Mental Health, the Hospice Education Network, and RWJF. Ms. Okun received her master’s degree from the Heller School for Social Policy and Management at Brandeis University. She completed study of palliative care and ethics at Memorial Sloan Kettering Cancer Center and was a fellow at the National Library of Medicine Program in Biomedical Informatics.
Bray Patrick-Lake, M.F.S., who is director of stakeholder engagement for the Clinical Trials Transformation Initiative (CTTI), supports efforts to actively engage patient advocacy organizations and other stakeholders in CTTI efforts to improve clinical trials. She also implements strategies to enhance awareness of CTTI’s work, particularly with patient advocates, and to extend the impact of CTTI results and recommendations. In 2010, after being a patient in an aborted clinical trial, Ms. Patrick-Lake founded the PFO Research Foundation in response to the lack of definitive scientific information regarding the condition of patent foramen ovale. Ms. Patrick-Lake has served as a patient representative at FDA on a variety of advisory committees and panels, in work groups for the European Medicines Agency and the National Institute of Neurological Disorders and Stroke at NIH, as a guest lecturer and an external reviewer for the IOM, and as a patient stakeholder or co-investigator for AHRQ and PCORI grants. She is a member of the PCORnet Coordinating Center’s Executive Leadership Committee, the ACC Foundation’s Patient-Centered Care (PC3) Shared Decision Making Workgroup, DIA’s Patient Fellowship Selection Committee, and the TVT Registry Stakeholder Advisory Committee and is a board member for the Alliance for Headache Disorders Advocacy. She holds a B.S. in zoology from the University of Georgia and a master of forensic sciences degree from National University in La Jolla, California.
Jonathan B. Perlin, M.D., Ph.D., M.S.H.A., FACP, FACMI, is the president of clinical services and chief medical officer of the Nashville, Tennessee–based HCA (Hospital Corporation of America). He provides leadership for clinical services and improving performance at HCA’s 166 hospitals and more than 800 outpatient centers and physician practices. Current activities include implementing EHRs throughout HCA, improving clinical “core measures” to benchmark levels, and leading patient safety programs to eliminate preventable complications and health care-associated infections. Before joining HCA in 2006, Dr. Perlin was Under Secretary for Health in the VA. Nominated by the President and confirmed by the Senate as the senior-most physician in the federal government and CEO of the VHA, Dr. Perlin led the nation’s largest integrated health system. At the VHA, Dr. Perlin directed care to more than 5.4 million patients annually from more than 200,000 health care professionals at 1,400 sites, including hospitals, clinics, nursing homes, counseling centers, and other facilities, with an operating and capital budget of more than $34 billion. A champion for the implementation of EHRs, Dr. Perlin led the VHA quality performance to international recognition, as reported in academic literature and lay press and as evaluated by RAND, the IOM, and others. Dr. Perlin has served previously on numerous boards and commissions, including the National Quality Forum and The Joint Commission, and he currently serves on the boards of the National Patient Safety Foundation and Meharry Medical College. He chairs the HHS Health Information Technology Standards Committee and has been elected chair of the AHA for 2015. Recognized perennially as one of the most influential physician executives in the United States by Modern Healthcare magazine, Dr. Perlin has received numerous awards, including Distinguished Alumnus in Medicine and Health Administration from his alma mater, the Chairman’s Medal from the National Patient Safety Foundation, and the Founders Medal from the Association of Military Surgeons of the United States, and he is one of a dozen honorary members of the Special Forces Association and Green Berets. Broadly published in health care quality and transformation, Dr. Perlin is a fellow of the American College of Physicians and of the American College of Medical Informatics. He has a master’s of science in health administration and received his Ph.D. in pharmacology (molecular neurobiology) with his M.D. as part of the Physician Scientist Training Program at the Medical College of Virginia of Virginia Commonwealth University (VCU). Dr. Perlin has faculty appointments at Vanderbilt University as adjunct professor of medicine and biomedical informatics and at VCU as adjunct professor of health administration.
Rita F. Redberg, M.D., M.Sc., has been a cardiologist and a professor of medicine and the director of women’s cardiovascular services at UC San
Francisco since 1990. Dr. Redberg is currently the chief editor of JAMA Internal Medicine (formerly Archives of Internal Medicine) and has spearheaded the journal’s new focus on health care reform and “less is more,” which highlights areas of health care with no known benefit and definite risks. Her research interests are in the area of health policy and technology assessment and how to promote high-value care, focusing on high-risk medical devices as well as the need for inclusion of women in clinical trials of such devices. Dr. Redberg is a member of the Medicare Payment Advisory Commission, which advises Congress on Medicare payment issues. She also served on the Medicare Evidence, Development and Coverage Advisory Committee from 2003 to 2006 and was reappointed in 2012 as chairwoman of the Medicare Evidence Development & Coverage Advisory Committee. Dr. Redberg is a member of the California Technology Assessment Forum, the Medical Policy Technology and Advisory Committee, and the FDA Cardiovascular Devices Expert Panel, and she is a consultant for the Center for Medical Technology Policy. She has given congressional testimony multiple times in hearings related to the issue of balancing safety and innovation in medical device approvals. Dr. Redberg worked in the office of Senator Hatch and with the Senate Judiciary Committee on FDA-related matters during her tenure as a RWJF Health Policy Fellow from 2003 to 2006. Dr. Redberg was a member of the IOM’s Learning Health Care Committee, which produced the report Best Care at Lower Cost in September 2012. She chaired the AHA/ACC Writing Group on Primary Prevention Performance Measures, is a member of the American College of Cardiology’s Clinical Quality Committee, and serves on the Quality in Technology Work Group. She is on multiple technology assessment boards, including the Blue Cross Blue Shield Medical Advisory Panel and the California Technology Assessment Forum as well as the Institute of Clinical and Economic Review Advisory Board. Dr. Redberg has authored several books, including You Can Be a Woman Cardiologist, Heart Healthy: The Step-by-Step Guide to Preventing and Healing Heart Disease, and Betty Crocker Cookbook for Women: The Complete Guide to Women’s Health and Wellness at Every Stage of Life. She has done hundreds of radio, television, and newspaper interviews on health-related topics, including being featured in the New York Times, the Wall Street Journal, USA Today, National Public Radio, and the Today Show. Dr. Redberg graduated from Cornell University and the University of Pennsylvania Medical School and has a master’s of science in health policy and administration from the London School of Economics.
J. James Rohack, M.D., is the chief health policy officer for Baylor Scott & White Health. He is a board-certified senior staff cardiologist at Baylor Scott & White Central Division in Temple, Texas, where he holds the William R. Courtney Centennial Endowed Chair in Medical Humanities
and serves as the director of the Center for Healthcare Policy and medical director for system improvement of the Scott & White Health Plan. He is a full professor in both the Department of Medicine and the Department of Humanities at the Texas A&M University Health Science Center College of Medicine. He served as the 164th president of the American Medical Association (AMA) in 2009–2010, being the face of the AMA during the national debate on American health care reform. He has served as treasurer of the board of commissioners of The Joint Commission, chaired the National Advisory Council to AHRQ, was one of the principals of the Hospital Quality Alliance and a member of the National Priorities Partnership. He is currently serving as co-chair of the steering committee of the Texas Care Alliance as well as on the executive committee of the national High-Value Healthcare Collaborative. He has been recognized as 1 of the 50 Most Powerful Physician Executives in Health Care, 1 of the 100 Most Powerful People in Health Care, 1 of America’s Top Physicians and Top Cardiologists, and the Texas Monthly Super Doctor.
Lewis G. Sandy, M.D., is the executive vice president of clinical advancement at the UnitedHealth Group, a Fortune 25 diversified health and well-being company dedicated to helping people live healthier lives. At UnitedHealth Group he focuses on clinical innovation, payment and delivery reforms to modernize our health care system, and physician collaboration. He also is a principal in the UnitedHealth Center for Health Reform and Modernization, with a focus on payment and delivery innovation and policy. From 2003 to 2007, he was executive vice president and chief medical officer of UnitedHealthcare, UnitedHealth Group’s largest business, focusing on the employer/individual health benefits market. From 1997 to 2003 he was executive vice president of RWJF. At RWJF he was responsible for the foundation’s program development and management, strategic planning, and administrative operations. Prior to this, Dr. Sandy was a program vice president of the foundation, focusing on the foundation’s workforce, health policy, and chronic care initiatives. An internist and former health center medical director at the Harvard Community Health Plan in Boston, Massachusetts, Dr. Sandy received his B.S. and M.D. degrees from the University of Michigan and an M.B.A. degree from Stanford University. A former RWJF Clinical Scholar and Clinical Fellow in Medicine at UC San Francisco, Dr. Sandy served his internship and residency at the Beth Israel Hospital in Boston. He is a senior fellow of the University of Minnesota School of Public Health, Department of Health Policy and Management.
Joe V. Selby, M.D., M.P.H., is the first executive director of PCORI. A family physician, clinical epidemiologist, and health services researcher, he has dedicated his career to patient care, clinical research, and adminis-
tration. At PCORI, he works to identify and address strategic issues and opportunities for PCORI and to implement and administer the research agenda authorized by the PCORI board of governors. Building on the foundational work of the board, Dr. Selby leads the continuing development of PCORI as a research organization, overseeing the implementation of its research agenda, its external communications, and its work to establish effective ongoing, two-way engagement channels with each of PCORI’s key stakeholder groups, beginning with patients. Dr. Selby joined PCORI from Kaiser Permanente, Northern California, where he was a researcher for 27 years, serving as director of the Division of Research for the past 13 years. In this role, he led a department of more than 50 investigators and 500 research staff working on more than 250 ongoing studies. An accomplished researcher, Dr. Selby has authored more than 220 peer-reviewed articles, primarily in the areas of primary care delivery; diabetes mellitus outcomes and quality improvement; colorectal cancer screening strategies; population management for chronic conditions; and quality measurement. Dr. Selby was elected to membership in the IOM in 2009. A native of Fulton, Missouri, Dr. Selby received his medical degree from Northwestern University, his training in family medicine from the Contra Costa County Family Medicine Program in Martinez, California, and his master’s in public health from UC Berkeley. He served as a commissioned officer in the Public Health Service with the National Health Service Corps from 1976 to 1983 and received the Commissioned Officer’s Award in 1981. Dr. Selby was appointed PCORI executive director on May 16, 2011.
Jean R. Slutsky, P.A., M.S.P.H., is the chief engagement and dissemination officer at PCORI. She leads PCORI’s engagement program and growing dissemination and implementation planning efforts. She also serves as director of PCORI’s Communication and Dissemination Research Program. Before joining PCORI, Ms. Slutsky directed the Center for Outcomes and Evidence at AHRQ, where she conceived and implemented the Effective Health Care program. The Effective Health Care program is an integrated program of research, stakeholder engagement, research training, and dissemination and implementation of comparative effectiveness research. Ms. Slutsky is particularly interested in pragmatic user-driven research and its implementation into health care decision making. Ms. Slutsky received her baccalaureate degree from the University of Iowa, trained as a physician assistant at the University of Southern California, and received an M.S.P.H. in health policy from the University of North Carolina at Chapel Hill.
Patricia Smith is president and CEO of the Alliance of Community Health Plans (ACHP), a national leadership organization in Washington, DC, that brings together high-quality, innovative health plans and provider groups.
A respected expert in delivery system reform, Medicare, and coordinated care issues, Ms. Smith works closely with ACHP’s 22 member organizations nationwide to promote learning, innovation, and public policy solutions to improve health, health care, affordability, and consumer experience. Prior to leading ACHP, Ms. Smith served as director of the Medicare Advantage Group at CMS. During her 2 years at CMS, she played a lead role in implementing the health plan changes and the Medicare Part D drug benefit in the Medicare Advantage program. Ms. Smith was previously vice president at America’s Health Insurance Plans and senior vice president for policy at ACHP from 2001 to 2004. For 15 years, she led federal health care lobbying efforts for AARP. Ms. Smith serves on the advisory board of the State of California’s Health Benefits Review Board, Kaiser Permanente’s Institute for Health Policy, the March of Dimes, and the Council of Accountable Physician Practices. She is a graduate of the College of William & Mary in Williamsburg, Virginia.
Glenn D. Steele, Jr., M.D., Ph.D., is president and CEO of Geisinger Health System, an integrated health services organization in central and northeastern Pennsylvania that is nationally recognized for its innovative use of the EHR and the development and implementation of innovative care models. Dr. Steele previously served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and vice president for medical affairs at the University of Chicago as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, president and CEO of Deaconess Professional Practice Group in Boston, Massachusetts, and chairman of the department of surgery at New England Deaconess Hospital (Boston). Dr. Steele is past chairman of the American Board of Surgery. His investigations have focused on the cell biology of gastrointestinal cancer and pre-cancer and most recently on innovations in health care delivery and financing. A prolific writer, he is the author or co-author of more than 483 scientific and professional articles. Dr. Steele received his bachelor’s degree in history and literature from Harvard University and his medical degree from New York University School of Medicine. He completed his internship and residency in surgery at the University of Colorado, where he was also a fellow of the American Cancer Society. He earned his Ph.D. in microbiology at Lund University in Sweden. A member of the IOM, Dr. Steele serves as a member on the Roundtable on Value & Science-Driven Health Care, was recently appointed to the Committee on the Governance and Financing of Graduate Medical Education, and previously served on the Committee on Reviewing Evidence to Identify Highly Effective Clinical Services. A fellow of the American College of Surgeons, Dr. Steele is a member of the American Surgical Association and the American Society of Clinical On-
cology and is past president of the Society of Surgical Oncology. Dr. Steele also serves on the following boards and national committees: Agency for Integrated Care Singapore, Bucknell University Board of Trustees, Cepheid Board of Directors, Congressional Budget Office Panel of Health Advisers, Harvard Medical Faculty Physicians Board at Beth Israel Deaconess Medical Center, Weis Markets Inc., Wellcare Health Plans Inc., xG Health Solutions board of directors, Healthcare Innovation Program external advisory board (Emory University), the Peterson Center on Healthcare advisory board, Institute for Healthcare Optimization advisory board, Third Rock Ventures Business advisory board, the State Health Care Cost Containment Commission, and Healthcare Executives Network. Dr. Steele most recently served as board chairman for Premier Inc. and is a former trustee on the Temple University School of Medicine board of visitors. Dr. Steele currently serves as honorary chair of the Pennsylvania March of Dimes Prematurity Campaign. He is a former member of the Commonwealth Fund’s Commission on a High Performance Health System, the National Commission for Quality Assurance’s (NCQA’s) Committee on Performance Measurement, and the AHA board of trustees, and he also served on the executive committee of the Systems Governing Council, Long-Range Policy, Committee on Research, and the AHA Physician Leadership Forum Advisory Committee. Dr. Steele is the recipient of several awards, including the CEO IT Achievement Award (2006); AHA’s Grassroots Champion Award (2007); the Eighth Annual (2010) AHA Health Research & Education Trust Award, and the HFMA Board of Directors’ Award (2011). He has been named consecutive times to Modern Healthcare’s 50.
John Steiner, M.D., M.P.H., has been the senior director of the Institute for Health Research at Kaiser Permanente Colorado since 2008. He currently serves as chair of the Kaiser Permanente National Research Council and as chairman of the governing board of the national HMO Research Network. Dr. Steiner received his B.A. degree from Yale University, his M.D. from the University of Pennsylvania School of Medicine, his internal medicine training at the University of Colorado, and his M.P.H. degree from the University of Washington, where he was an RWJF Clinical Scholar. Prior to 2008 he was a tenured professor in the Department of Medicine at the University of Colorado School of Medicine and the director of the Colorado Health Outcomes Program. In 2005 he received the Florence R. Sabin Award from the University of Colorado Health Sciences Center for his contributions to the university and the people of Colorado. From 2007 to 2011 he was the chair of the health systems research scientific review group for AHRQ. Dr. Steiner is the author or co-author of more than 200 publications that reflect his research interests in access to care, health disparities, prevention
Paul Wallace, M.D., is the chief medical officer and senior vice president for clinical translation at Optum Labs, which was launched in early 2013 with the Mayo Clinic as a founding partner. Based in Cambridge, Massachusetts, Optum Labs is designed to develop and sustain a community of research and learning partners spanning multiple health sectors who will have access to unprecedented data resources to work collaboratively on some of the most critical problems in health care today. From 2011 to 2013 Dr. Wallace was a senior vice president and director of the Center for Comparative Effectiveness Research at the Washington, DC–based Lewin Group, and before that he was a medical director and clinician with Kaiser Permanente from 1989 to 2011. He was the executive director of Kaiser Permanente’s Care Management Institute (CMI) from 2000 to 2005, and he led and contributed to several Kaiser Permanente national initiatives in evidence-based medicine, population health, and the use of health information technology. Dr. Wallace is currently chair of the board of directors for AcademyHealth and a board member of the eHealth Initiative, and he has served on national committees and boards for the IOM, NCQA, AHRQ, CMS, the Blue Cross and Blue Shield Technology Evaluation Center, the Center for Information Therapy, and the Care Continuum Alliance. Wallace is a graduate of the University of Iowa School of Medicine, and he completed further training in internal medicine and hematology at Strong Memorial Hospital and the University of Rochester.
John Warner, M.D., M.B.A., is CEO of the University of Texas (UT) Southwestern University Hospitals and Clinics and a professor of internal medicine in the Division of Cardiology. Dr. Warner holds the Jim and Norma Smith Distinguished Chair for Interventional Cardiology, the Audre and Bernard Rapoport Chair in Cardiovascular Research, and the Nancy and Jeremy Halbreich, Susan and Theodore Strauss Professorship in Cardiology. Dr. Warner received his medical degree from Vanderbilt University and his M.B.A. from the Physician Executive Program at the University of Tennessee. He completed residency training in internal medicine at UT Southwestern, where he served as chief resident. He completed fellowship training in cardiovascular disease and interventional cardiology at Duke University Medical Center, and he was a member of the Duke cardiology faculty from 2000 to 2002. Since joining the UT Southwestern faculty in 2003, Dr. Warner has served in many clinical and administrative leadership roles, including chief of staff for UT Southwestern University Hospitals, director of the Cardiac Catheterization Laboratories, and director of the Cardiology Fellowship Training Program. Prior to being named the CEO
of UT Southwestern University Hospitals in 2012, he served as medical director of the Doris and Harry W. Bass Jr. Clinical Center for Heart, Lung and Vascular Disease and assistant vice president for hospital planning. Dr. Warner is a fellow of the American College of Cardiology and is currently a member of the national board of directors of AHA, where he chairs the Advocacy Committee. He is past president of both the Dallas Division and the Southwest Affiliate of AHA.
James N. Weinstein, D.O., M.S., is the CEO and president of the Dartmouth–Hitchcock health system. The system includes New Hampshire’s only academic medical center and a network of clinics across Vermont and New Hampshire that serve a patient population of 1.5 million. Under Dr. Weinstein’s leadership, Dartmouth–Hitchcock is working to create a “sustainable health system” for patients, providers, payers, and communities. He is a member of the IOM. He serves on the IOM Committee on Advising the Social Security Administration on Disability. Most recently, Dr. Weinstein was one of four members appointed to the IOM Board on Population Health and Public Health Practice. Immediately prior to becoming CEO of Dartmouth–Hitchcock, Dr. Weinstein served as president of the Dartmouth–Hitchcock Clinic and director of The Dartmouth Institute for Health Policy and Clinical Practice (TDI). His dual positions as clinic president and TDI director allowed him to build critical linkages between the groundbreaking health services research of TDI and the clinical care at Dartmouth–Hitchcock. He is a founding member, along with the Mayo Clinic, Intermountain Healthcare, TDI, and Denver Health, of the national High Value Healthcare Collaborative, a partnership of 19 health systems across the country that have taken on the challenge of improving the quality of care while lowering costs. More than 70,000 physicians, who treat more than 100 million patients, are sharing best practices and data in an unprecedented partnership on behalf of patients. Dr. Weinstein is a leader in advancing “informed choice” to ensure that patients receive evidence-based, safe, effective, efficient, and appropriate care. In 1999 he established the first-in-the-nation Center for Shared Decision-Making at Dartmouth–Hitchcock, where patient preferences and values are an integral part of diagnostic and treatment decisions. He also pioneered the use of patient-reported outcomes in clinical practice in 1983, adding a new dimension to the process and clinical measurements traditionally used to judge the efficacy and value of care. This will become part of the federal government’s meaningful use criteria for EHRs by 2017. He is an internationally renowned spine surgeon and health services researcher, with more than 280 published articles and in excess of $70 million in federal research funding. He founded the multidisciplinary Spine Center at Dartmouth–Hitchcock, which has become an international model for patient-centered
health care delivery. Additionally, he is editor in chief of Spine, an international, peer-reviewed, multidisciplinary journal, ranked No. 1 in its field by SCI. Dr. Weinstein holds the Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at Dartmouth. He has been named 1 of “The 100 Most Influential People in Healthcare” by Modern Healthcare magazine and is frequently consulted by members of Congress and the administration on health policy and reform, and he has appeared before several panels and committees considering these issues.